Cargando…

Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models

Structural changes and neuropathology in the hypothalamus have been suggested to contribute to the non-motor manifestations of Huntington’s disease (HD), a neurodegenerative disorder caused by an expanded cytosine-adenine-guanine (CAG) repeat in the huntingtin (HTT) gene. In this study, we investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Dickson, Elna, Dwijesha, Amoolya Sai, Andersson, Natalie, Lundh, Sofia, Björkqvist, Maria, Petersén, Åsa, Soylu-Kucharz, Rana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671106/
https://www.ncbi.nlm.nih.gov/pubmed/36408416
http://dx.doi.org/10.3389/fnins.2022.1027269
_version_ 1784832470757146624
author Dickson, Elna
Dwijesha, Amoolya Sai
Andersson, Natalie
Lundh, Sofia
Björkqvist, Maria
Petersén, Åsa
Soylu-Kucharz, Rana
author_facet Dickson, Elna
Dwijesha, Amoolya Sai
Andersson, Natalie
Lundh, Sofia
Björkqvist, Maria
Petersén, Åsa
Soylu-Kucharz, Rana
author_sort Dickson, Elna
collection PubMed
description Structural changes and neuropathology in the hypothalamus have been suggested to contribute to the non-motor manifestations of Huntington’s disease (HD), a neurodegenerative disorder caused by an expanded cytosine-adenine-guanine (CAG) repeat in the huntingtin (HTT) gene. In this study, we investigated whether hypothalamic HTT expression causes transcriptional changes. Hypothalamic RNA was isolated from two different HD mouse models and their littermate controls; BACHD mice with ubiquitous expression of full-length mutant HTT (mHTT) and wild-type mice with targeted hypothalamic overexpression of either wild-type HTT (wtHTT) or mHTT fragments. The mHTT and wtHTT groups showed the highest number of differentially expressed genes compared to the BACHD mouse model. Gene Set Enrichment Analysis (GSEA) with leading-edge analysis showed that suppressed sterol- and cholesterol metabolism were shared between hypothalamic wtHTT and mHTT overexpression. Most distinctive for mHTT overexpression was the suppression of neuroendocrine networks, in which qRT-PCR validation confirmed significant downregulation of neuropeptides with roles in feeding behavior; hypocretin neuropeptide precursor (Hcrt), tachykinin receptor 3 (Tacr3), cocaine and amphetamine-regulated transcript (Cart) and catecholamine-related biological processes; dopa decarboxylase (Ddc), histidine decarboxylase (Hdc), tyrosine hydroxylase (Th), and vasoactive intestinal peptide (Vip). In BACHD mice, few hypothalamic genes were differentially expressed compared to age-matched WT controls. However, GSEA indicated an enrichment of inflammatory- and gonadotropin-related processes at 10 months. In conclusion, we show that both wtHTT and mHTT overexpression change hypothalamic transcriptome profile, specifically mHTT, altering neuroendocrine circuits. In contrast, the ubiquitous expression of full-length mHTT in the BACHD hypothalamus moderately affects the transcriptomic profile.
format Online
Article
Text
id pubmed-9671106
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96711062022-11-18 Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models Dickson, Elna Dwijesha, Amoolya Sai Andersson, Natalie Lundh, Sofia Björkqvist, Maria Petersén, Åsa Soylu-Kucharz, Rana Front Neurosci Neuroscience Structural changes and neuropathology in the hypothalamus have been suggested to contribute to the non-motor manifestations of Huntington’s disease (HD), a neurodegenerative disorder caused by an expanded cytosine-adenine-guanine (CAG) repeat in the huntingtin (HTT) gene. In this study, we investigated whether hypothalamic HTT expression causes transcriptional changes. Hypothalamic RNA was isolated from two different HD mouse models and their littermate controls; BACHD mice with ubiquitous expression of full-length mutant HTT (mHTT) and wild-type mice with targeted hypothalamic overexpression of either wild-type HTT (wtHTT) or mHTT fragments. The mHTT and wtHTT groups showed the highest number of differentially expressed genes compared to the BACHD mouse model. Gene Set Enrichment Analysis (GSEA) with leading-edge analysis showed that suppressed sterol- and cholesterol metabolism were shared between hypothalamic wtHTT and mHTT overexpression. Most distinctive for mHTT overexpression was the suppression of neuroendocrine networks, in which qRT-PCR validation confirmed significant downregulation of neuropeptides with roles in feeding behavior; hypocretin neuropeptide precursor (Hcrt), tachykinin receptor 3 (Tacr3), cocaine and amphetamine-regulated transcript (Cart) and catecholamine-related biological processes; dopa decarboxylase (Ddc), histidine decarboxylase (Hdc), tyrosine hydroxylase (Th), and vasoactive intestinal peptide (Vip). In BACHD mice, few hypothalamic genes were differentially expressed compared to age-matched WT controls. However, GSEA indicated an enrichment of inflammatory- and gonadotropin-related processes at 10 months. In conclusion, we show that both wtHTT and mHTT overexpression change hypothalamic transcriptome profile, specifically mHTT, altering neuroendocrine circuits. In contrast, the ubiquitous expression of full-length mHTT in the BACHD hypothalamus moderately affects the transcriptomic profile. Frontiers Media S.A. 2022-11-03 /pmc/articles/PMC9671106/ /pubmed/36408416 http://dx.doi.org/10.3389/fnins.2022.1027269 Text en Copyright © 2022 Dickson, Dwijesha, Andersson, Lundh, Björkqvist, Petersén and Soylu-Kucharz. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Dickson, Elna
Dwijesha, Amoolya Sai
Andersson, Natalie
Lundh, Sofia
Björkqvist, Maria
Petersén, Åsa
Soylu-Kucharz, Rana
Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
title Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
title_full Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
title_fullStr Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
title_full_unstemmed Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
title_short Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
title_sort microarray profiling of hypothalamic gene expression changes in huntington’s disease mouse models
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671106/
https://www.ncbi.nlm.nih.gov/pubmed/36408416
http://dx.doi.org/10.3389/fnins.2022.1027269
work_keys_str_mv AT dicksonelna microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels
AT dwijeshaamoolyasai microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels
AT anderssonnatalie microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels
AT lundhsofia microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels
AT bjorkqvistmaria microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels
AT petersenasa microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels
AT soylukucharzrana microarrayprofilingofhypothalamicgeneexpressionchangesinhuntingtonsdiseasemousemodels